Claims (28)
항 경련 효과를 갖는 하기 일반식(Ⅰ)화합물.The following general formula (I) compound having an anticonvulsant effect.
상기 구조식(Ⅰ)에서, R1은 알콕시알킬, 디알콕시아킬, (1,3-디옥소란-2-일) 알킬, (1,3-디옥소란-4-메틸-2-일)알킬, (1,3-디옥소란-2-메틸-2-일) 알킬, (1,3-벤조디옥솔-2-일) 알킬 도는 벤젠핵에 알킬, 알콕시 또는 할로겐이 치환된 (1,3-벤조디옥솔-2-일) 알킬기이며 ; R2는 수소, 알킬 또는 알릴기이며 ; R3와 R4는 수소 또는 알킬기이고 이들 치환기가 서로 같거나 다르게 치환되어 있다.In formula (I), R 1 is alkoxyalkyl, dialkoxyacyl, (1,3-dioxolan-2-yl) alkyl, (1,3-dioxolane-4-methyl-2-yl) alkyl , (1,3-dioxolane-2-methyl-2-yl) alkyl, (1,3-benzodioxol-2-yl) alkyl or benzene nucleus substituted by alkyl, alkoxy or halogen (1,3 -Benzodioxol-2-yl) alkyl group; R 2 is hydrogen, alkyl or allyl group; R 3 and R 4 are hydrogen or an alkyl group and these substituents are the same as or different from each other.
제 1 항에 있어서 구조식(Ⅰ) 화합물을 주성분으로 하여 약제학적으로 허용되는 부형제 또는 용매를 사용하여, 경련을 예방, 억제 또는 치료할 목적을 약리학적 유효량을 함유하는 약제학적인 조면.A pharmaceutical groyne according to claim 1 which contains a pharmacologically effective amount for the purpose of preventing, inhibiting or treating convulsions using a pharmaceutically acceptable excipient or solvent mainly comprising the compound of formula (I).
1-(2,2-디메톡시) 에틸-3-메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-methyl-2-thiohydantoin.
1-(2,2-디메톡시) 에틸-3-에틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-ethyl-2-thiohydantoin.
1-(2,2-디메톡시) 에틸-3-알릴-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-allyl-2-thiohydantoin.
1-(2,2-디메톡시) 에틸-3-메틸-5,5-디메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-methyl-5,5-dimethyl-2-thiohydantoin.
1-(2-메톡시에틸)-3-메틸-2-티오히단토인.1- (2-methoxyethyl) -3-methyl-2-thiohydantoin.
1-(2-메톡시에틸)-3-알릴-2-티오히단토인.1- (2-methoxyethyl) -3-allyl-2-thiohydantoin.
1-(3,3-디메톡시)프로필-3-메틸-2-티오히단토인.1- (3,3-dimethoxy) propyl-3-methyl-2-thiohydantoin.
1-(2,2-디메톡시) 에틸-3-메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-methyl-2-thiohydantoin.
1-(2-(1,3-디옥소란-2-일)에틸]-3-메틸-2-티오히단토인.1- (2- (1,3-dioxolan-2-yl) ethyl] -3-methyl-2-thiohydantoin.
1-(1,3-디옥소란-2-일)메틸-2-티오히단토인.1- (1,3-dioxolan-2-yl) methyl-2-thiohydantoin.
1-(1,3-디옥소란-2-메틸-2-일)메틸-2-티오히단토인.1- (1,3-dioxolane-2-methyl-2-yl) methyl-2-thiohydantoin.
1-(1,3-디옥소란-4-메틸-2-일)메틸-2-티오히단토인.1- (1,3-dioxoran-4-methyl-2-yl) methyl-2-thiohydantoin.
1-(1,3-벤조디옥솔-2-일)메틸-3-메틸-2-티오히단토인.1- (1,3-benzodioxol-2-yl) methyl-3-methyl-2-thiohydantoin.
1-(2,2-디메톡시)에틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-2-thiohydantoin.
1-(2,2-디메톡시)에틸-5-메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-5-methyl-2-thiohydantoin.
1-(2,2-디메톡시)에틸-5,5-디메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-5,5-dimethyl-2-thiohydantoin.
1-(1,3-디옥소란-2-일)-메틸-2-티오히단토인.1- (1,3-dioxolan-2-yl) -methyl-2-thiohydantoin.
1-(1,3-벤조디옥솔-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-2-yl) methyl-2-thiohydantoin.
1-(1,3-벤조디옥솔-5-메틸-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-5-methyl-2-yl) methyl-2-thiohydantoin.
1-(1,3-벤조디옥솔-4-메톡시-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-4-methoxy-2-yl) methyl-2-thiohydantoin.
1-(1,3-벤조디옥솔-5-클로로-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-5-chloro-2-yl) methyl-2-thiohydantoin.
1-(1,3-벤조디옥솔-5-풀루오로-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-5- pulluro-2-yl) methyl-2-thiohydantoin.
아래 구조식(Ⅰ) 화합물을 구조식(Ⅱ)와 (Ⅲ)화합물을 반응시켜 제조하는 방법.A method for preparing a compound of formula (I) below by reacting a compound of formula (II) with (III)
상기구조식(Ⅰ)에서, R1은 알콕시알킬, 디알콕시알킬, (1,3-디옥소란-2-일) 알킬, (1,3-디옥소소란-2-메틸-2-일) 알킬, (1,3-디옥소란-4-메틸-2-일) 알킬, (1,3-벤조디옥솔-2-일) 알킬 또는 벤젠핵에 알킬, 알콕시 또는 할로겐이 치환된 (1,3-벤조디옥솔-2-일) 알킬이며 ; R2는 수소, 알킬 또는 알릴기이고 ; R3와 R4는 수소 또는 알킬기를 나타내며, 서로 같거나 서로 다르게 치환되어 있다. 상기 구조식(Ⅱ)에서 R1, R3및 R4는 구조식(Ⅰ)에서 정의한 바와같고, R5는 탄소수 1∼4개의 알킬 또는 벤질이며, 구조식(Ⅲ)에서 R2는 수소를 제외하고 상기 구조식(Ⅰ)에서 정의한 바와 같다.In the above formula (I), R 1 is alkoxyalkyl, dialkoxyalkyl, (1,3-dioxolan-2-yl) alkyl, (1,3-dioxoranan-2-methyl-2-yl) alkyl (1,3 with alkyl, alkoxy or halogen substituted in (1,3-dioxoran-4-methyl-2-yl) alkyl, (1,3-benzodioxol-2-yl) alkyl or benzene nucleus -Benzodioxol-2-yl) alkyl; R 2 is hydrogen, alkyl or allyl group; R 3 and R 4 represent hydrogen or an alkyl group, and are the same as or different from each other. In formula (II), R 1 , R 3 and R 4 are as defined in formula (I), R 5 is alkyl or benzyl having 1 to 4 carbon atoms, and in formula (III), R 2 except hydrogen As defined in Structural Formula (I).
제 25 항의 구조식(Ⅰ) 화합물에서 R2가 수소인 화합물을 구조식(Ⅱ) 글리신 에틸에스테르 유도체를 벤조일이소티오시아네이트와 반응시켜 구조식(Ⅳ) N-벤조일 티오카바모일 글리신 에스테르 유도체를 합성하고 트리에틸아민 또는 피리딘과 같은 염기성 용매에서 환화하여 구조식(Ⅰ) 화합물을 제조하는 방법.A compound wherein R 2 is hydrogen in the compound of formula (I) according to claim 25 is synthesized by reacting a compound of formula (II) glycine ethyl ester derivative with benzoylisothiocyanate to formulate (IV) N-benzoyl thiocarbamoyl glycine ester derivative and A process for preparing the compound of formula (I) by cyclization in a basic solvent such as ethylamine or pyridine.
제 26 항에 있어서, 반응이 구조식(Ⅰ)의 3위치 질소원자에 벤조일기가 치환된 구조식(Ⅴ)의 화합물로 종결된 경우, 구조식(Ⅴ)화합물을 분리하고 수산화나트륨 수용액에서 가수분해하여 구조식(Ⅰ) 화합물을 제조하는 방법.27. The compound of claim 26, wherein the reaction is terminated with a compound of formula (V) in which a benzoyl group is substituted for a 3-position nitrogen atom of formula (I), the compound of formula (V) is separated and hydrolyzed in aqueous sodium hydroxide solution I) A method for preparing a compound.
구조식(Ⅰ) 화합물의 1위치의 질소원자에 아세탈알킬기가 치환된 경우, 산촉매 존재하에서 알콜과 아세탈 교환반응을 실시하여 해당하는 알콜의 아세탈 유도체를 제조하는 방법.A method for producing an acetal derivative of an alcohol by carrying out an acetal exchange reaction with an alcohol in the presence of an acid catalyst when the nitrogen atom at the 1 position of the compound of formula (I) is substituted.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.